↓ Skip to main content

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

Overview of attention for article published in Stem Cell Research & Therapy, July 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment
Published in
Stem Cell Research & Therapy, July 2022
DOI 10.1186/s13287-022-02972-3
Pubmed ID
Authors

Lei Shi, You Zheng, Zhi Cheng, Ningfei Ji, Changming Niu, Yan Wang, Tingrong Huang, Ruyou Li, Mao Huang, Xiaolin Chen, Lei Shu, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan, Ganzhu Feng

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 13%
Other 3 10%
Student > Ph. D. Student 3 10%
Student > Master 3 10%
Student > Bachelor 2 7%
Other 2 7%
Unknown 13 43%
Readers by discipline Count As %
Medicine and Dentistry 6 20%
Biochemistry, Genetics and Molecular Biology 4 13%
Agricultural and Biological Sciences 2 7%
Nursing and Health Professions 1 3%
Chemistry 1 3%
Other 1 3%
Unknown 15 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2023.
All research outputs
#15,973,953
of 25,713,737 outputs
Outputs from Stem Cell Research & Therapy
#1,284
of 2,788 outputs
Outputs of similar age
#213,476
of 437,304 outputs
Outputs of similar age from Stem Cell Research & Therapy
#47
of 149 outputs
Altmetric has tracked 25,713,737 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,788 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,304 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 149 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.